Discover and read the best of Twitter Threads about #ResearchSpotlight
Most recents (2)
It's #ResearchSpotlight time! Today, we're shining the spotlight on Professor Francesco Forconi...
🔬 Follicular lymphoma and diffuse large B cell lymphoma (DLBCL) are the two most common types of non-Hodgkin #lymphoma.
🔬 Follicular lymphoma and diffuse large B cell lymphoma (DLBCL) are the two most common types of non-Hodgkin #lymphoma.
We can treat this disease, but many treatments have harsh side effects.
💊 Professor Forconi from the University of Southampton wants to find better ways to treat these diseases.
💊 Professor Forconi from the University of Southampton wants to find better ways to treat these diseases.
🏷️ The team are studying ‘tags’ found on the surface of lymphoma cells, which they think tell the immune system to ignore the cancer cells. This means cancerous cells are not destroyed and are allowed to divide and grow in numbers.
Today is #BiomedicalScienceDay2020 - and what better way to celebrate than sharing our latest #ResearchSpotlight with you all!
🔬 This month we're celebrating the work of Professor James Allan, who leads on a Blood Cancer UK funded project and is based at the @UniofNewcastle.
🔬 This month we're celebrating the work of Professor James Allan, who leads on a Blood Cancer UK funded project and is based at the @UniofNewcastle.
💉 James' work is about understanding how unique genetic changes in acute myeloid leukaemia (AML) can be used to tailor treatment.
🧓 AML is most common in the elderly and many of these people cannot have #chemotherapy because of the harsh side effects it causes.
🧓 AML is most common in the elderly and many of these people cannot have #chemotherapy because of the harsh side effects it causes.
💊 To get around this, James and his team are looking to find ways of using other existing therapies more strategically, based on specific characteristics of these peoples' disease. This is called "stratified medicine."
